Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7426 AL 7440

[Donanemab, an Amyloid β-targeting Antibody for Early Symptomatic Alzheimer's Disease: Summary of Clinical Study Results]

Sato S, Iwata A, Ishii K, Kamiki E, Nishimoto T.

Brain Nerve. 2025 Aug;77(8):907-920. doi: 10.11477/mf.188160960770080907.

[The mechanism of PI3K/AKT pathway in Alzheimer's disease and the research progress of acupuncture intervention]

Chen YZ, Wei YT, Xiao M, Xie WT, Yan XK.

Zhen Ci Yan Jiu. 2025 Aug 25;50(8):965-973. doi: 10.13702/j.1000-0607.20240371.

Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer's disease

Wasim R.

Inflammopharmacology. 2025 Sep;33(9):5273-5289. doi: 10.1007/s10787-025-01916-6. Epub 2025 Aug 27.

Nanoparticles as an Encouraging Therapeutic Approach to Alzheimer's Disease

Koga-Batko J, Antosz-Popiołek K, Nowakowska H, Błażejewska M, Kowalik EM, Beszłej JA, Leszek J.

Int J Mol Sci. 2025 Aug 10;26(16):7725. doi: 10.3390/ijms26167725.

The Therapeutic Potential of Flavonols in Alzheimer's Disease: Inhibiting Amyloid-β, Oxidative Stress, and Neuroinflammation

Zamanian MY, Khachatryan LG, Heidari M, Darabi R, Golmohammadi M, Al-Aouadi RFA, Akkol EK.

Biofactors. 2025 Sep-Oct;51(5):e70047. doi: 10.1002/biof.70047.

Harnessing nanoparticles for Alzheimer's disease: Innovations in drug delivery and pathology-specific treatments

Liu G, Sun Y.

J Alzheimers Dis. 2025 Oct;107(4):1374-1399. doi: 10.1177/13872877251374149. Epub 2025 Sep 3.

Therapeutic potential of small peptides in Alzheimer's disease: Advances in memory restoration and targeted delivery systems

Verma P, Khatun R, Jew KA, Prusty SK, Knafo S.

Neuropeptides. 2025 Dec;114:102559. doi: 10.1016/j.npep.2025.102559. Epub 2025 Sep 5.

Antibody Therapies for Alzheimer's Disease: A New Strategy for Targeted Therapy and Blood-Brain Barrier Delivery

Feng X, Wang H.

ACS Chem Neurosci. 2025 Sep 17;16(18):3450-3464. doi: 10.1021/acschemneuro.5c00484. Epub 2025 Sep 7.

Discovery of natural compounds and their derivatives against neuroinflammation: Pharmacological mechanisms and structure-activity relationship

Xin X, Zong T, Hu Z, Jin L, Zhou W, Sun J, Li G.

Bioorg Chem. 2025 Oct;165:108934. doi: 10.1016/j.bioorg.2025.108934. Epub 2025 Aug 30.

Targeting mitochondrial dysfunction in Alzheimer's disease: New findings and perspectives

Hroudová J, Fišar Z.

Prog Neuropsychopharmacol Biol Psychiatry. 2025 Oct 2;142:111491. doi: 10.1016/j.pnpbp.2025.111491. Epub 2025 Sep 9.

Review of anti-amyloid-beta (Aβ) monoclonal antibodies for the treatment of Alzheimer's disease

Francis E, Paylor S, Van C, Mathews B, Sobhanian MJ, Mansour DZ, Hennawi G, Brandt NJ.

Expert Rev Clin Pharmacol. 2025 Dec;18(12):1063-1078. doi: 10.1080/17512433.2025.2556122. Epub 2025 Sep 22.

Nanotechnology-driven approaches for the early detection and targeted treatment of Alzheimer's disease

Sharma DK.

J Drug Target. 2026 Mar;34(3):372-389. doi: 10.1080/1061186X.2025.2561788. Epub 2025 Sep 19.

Integrating molecular imaging with near-infrared theranostics to improve early detection and therapy of Alzheimer's disease

Mahajan G, Pandya K, Tripathi A, Kumar D.

Bioorg Chem. 2025 Oct;165:108949. doi: 10.1016/j.bioorg.2025.108949. Epub 2025 Sep 11.

Neutrophils and NETosis in Alzheimer's disease: Unraveling pathogenic mechanisms and novel therapeutic targets

Chavoshinezhad S, Beirami E, Izadpanah E.

Biomed Pharmacother. 2025 Nov;192:118568. doi: 10.1016/j.biopha.2025.118568. Epub 2025 Sep 18.

The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer's Disease

Moorthy H, Sain S, Padhi D, Govindaraju T.

J Med Chem. 2025 Oct 9;68(19):19828-19845. doi: 10.1021/acs.jmedchem.5c00917. Epub 2025 Sep 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias